skip to main content
Visitante
Meu Espaço
Minha Conta
Sair
Identificação
This feature requires javascript
Tags
Revistas Eletrônicas (eJournals)
Livros Eletrônicos (eBooks)
Bases de Dados
Bibliotecas USP
Ajuda
Ajuda
Idioma:
Inglês
Espanhol
Português
This feature required javascript
This feature requires javascript
Primo Search
Busca Geral
Busca Geral
Acervo Físico
Acervo Físico
Produção Intelectual da USP
Produção USP
Search For:
Clear Search Box
Search in:
Busca Geral
Or select another collection:
Search in:
Busca Geral
Busca Avançada
Busca por Índices
This feature requires javascript
This feature requires javascript
HIVAN, Adult
Trachtman, Howard ; Herlitz, Leal C ; Lerma, Edgar V ; Hogan, Jonathan J
Glomerulonephritis, 2019, p.509-521
Switzerland: Springer International Publishing AG
Sem texto completo
Citações
Citado por
Serviços
Detalhes
Resenhas & Tags
Nº de Citações
This feature requires javascript
Enviar para
Adicionar ao Meu Espaço
Remover do Meu Espaço
E-mail (máximo 30 registros por vez)
Imprimir
Link permanente
Referência
EasyBib
EndNote
RefWorks
del.icio.us
Exportar RIS
Exportar BibTeX
This feature requires javascript
Título:
HIVAN, Adult
Autor:
Trachtman, Howard
;
Herlitz, Leal C
;
Lerma, Edgar V
;
Hogan, Jonathan J
Assuntos:
Antiretroviral therapy
;
HIV
;
HIV immune complex kidney disease
;
HIV-associated nephropathy
É parte de:
Glomerulonephritis, 2019, p.509-521
Descrição:
HIV infection is associated with an increased incidence of acute and chronic kidney disease. HIV-positive individuals are at risk for HIV-associated glomerular diseases, including HIV-associated nephropathy (HIVAN) and HIV immune complex kidney disease, but are also susceptible to antiretroviral nephrotoxicity and comorbid kidney disease. Kidney biopsy is required for definitive diagnosis in the majority of cases. HIVAN is a collapsing form of focal segmental glomerulosclerosis with associated tubulointerstitial lesions, occurring primarily in individuals of African descent who have advanced HIV disease. The first-line treatment of HIVAN is antiretroviral therapy, with the addition of ACE inhibitors or angiotensin receptor blockers as adjunctive therapy. The role of antiretroviral therapy is less clear in HIV immune complex kidney disease and comorbid kidney disease. Even with effective therapy, HIV-positive individuals are at increased risk of progression to end-stage renal disease. The management of end-stage renal disease is largely based on guidelines developed for the general population, with special consideration of drug–drug interactions in patients with well-controlled HIV infection who may be candidates for kidney transplantation.
Editor:
Switzerland: Springer International Publishing AG
Idioma:
Inglês
This feature requires javascript
This feature requires javascript
Voltar para lista de resultados
This feature requires javascript
This feature requires javascript
Buscando em bases de dados remotas. Favor aguardar.
Buscando por
em
scope:(USP_PRODUCAO),scope:(USP_EBOOKS),scope:("PRIMO"),scope:(USP),scope:(USP_EREVISTAS),scope:(USP_FISICO),primo_central_multiple_fe
Mostrar o que foi encontrado até o momento
This feature requires javascript
This feature requires javascript